ʻO Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Maʻemaʻe >99.0% (HPLC) API Hale Kūʻai Kūlana Kiʻekiʻe

ʻO ka wehewehe pōkole:

Inoa Kemika: Sitagliptin Phosphate Monohydrate

CAS: 654671-77-9

Maʻemaʻe: >99.0% (HPLC ma ke kumu maloʻo)

ʻAno: Keʻokeʻo a i ʻole-White Crystalline Powder

No ka mālama ʻana i ka maʻi diabetes type II

API Kūlana Kiʻekiʻe, Hana Hana Kūʻai

E-Mail: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Na Waiwai Kemika:

Inoa Kimia ʻO Sitagliptin Phosphate Monohydrate
Nā huaʻōlelo like (R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4- (2,4,5-trifluorophenyl)butan-1-hoʻokahi phosphate monohydrate
Helu CAS 654671-77-9
Kūlana Kūʻai Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala C16H20F6N5O6P
Kaumaha Molecular 523.3240802
Lae hehee 202.0~204.0 ℃
Hiki i ka wai Hiki i ka wai
Hoʻololi kikoʻī -18.0°~-23.0° (C=1, Wai)
Brand Kemika Ruifu

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Keʻokeʻo a i ka pauka kristal keʻokeʻo
ʻIke ʻia e HPLC ʻO ka manawa paʻa o ka laʻana ua kūlike me ka maʻamau kuhikuhi
IR-Infrared Spectrum E kūlike ka IR Absorption Spectrum o ka hāpana me ka spectrum maʻamau
Phosphate Hoʻokō
Maʻemaʻe / Kaʻina Hanana >99.0% (HPLC ma ke kumu maloʻo)
Waiwai (KF) 3.3%~4.4%
Koena ma ka Ignition ≤0.20%
Sulphate ≤0.02%
Klorida ≤0.05%
Ka haumia ʻo Chiral <0.50%
Na mea pili
Hoʻokahi haumia <0.50%
Huina paumaele <1.0%
Ethyl Acetate <0.50%
Nā Metala Kaumaha <20ppm
Kūlana hoʻāʻo Kūlana ʻoihana
Hoʻohana Nā Kūwaena Lapaʻau

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai.

Pono:

1

FAQ:

Noi:

ʻO Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9), he lāʻau hou no ka mālama ʻana i ka maʻi maʻi type 2.I ʻAukake 2009, ua ʻae ʻia ka lāʻau lapaʻau e ka European Union ma ke ʻano he lāʻau lapaʻau mua no ka mālama ʻana i ka maʻi diabetes type 2.ʻO Sitagliptin Phosphate ka mea mua i ʻae ʻia e ka FDA i ka dipeptidyl peptidase-IV inhibitor e hoʻohana ʻia i ka mālama ʻana i ka maʻi diabetes type 2 ma kahi mamao, ma lalo o ka inoa kālepa Januvia.ʻO Dipeptidylpeptidase Ⅳ (DPP-Ⅳ) wikiwiki a hoʻohaʻahaʻa i ka GLP-1, GLP-1, ʻo ia ka mea hoʻoulu maikaʻi loa o ka hana ʻana o ka insulin a me ka huna ʻana No laila, hiki i ka inhibition o DPP-IV ke hoʻonui i ka hana o ka endogenous GLP-1, a laila e hoʻonui ai i ke koko. ka pae o ka insulin, ma laila e hoʻemi a mālama i nā pae glucose koko i nā maʻi maʻi maʻi.I kēia manawa, ua hōʻoia ka lāʻau lapaʻau ʻo DPP-IV inhibitor kahi ʻano hou o ka lāʻau anti-diabetic, a hōʻike nā hopena lapaʻau he hopena hypoglycemic maikaʻi nā lāʻau.Ma muli o ka hana ʻana o ka GLP-1 i ka glucose i ka hoʻoikaika ʻana i ka hana ʻana a me ka huna ʻana o ka insulin, ʻaʻole hiki mai nā hopena ʻino maʻamau e like me ka hypoglycemia a me ka piʻi ʻana o ke kaumaha ma muli o ka hoʻohana ʻana i nā lāʻau antidiabetic.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou